Mettler-Toledo International Inc at Barclays Global Healthcare Conference Transcript
And good afternoon, everybody. My name is Jack Meehan, I am the Life Science Tools and Diagnostics Analyst at Barclays. And really pleased to be joined by Mettler-Toledo today and the company's CFO, Shawn Vadala as well as Mary Finnegan, the company's Treasurer and Head of Investor Relations. Before we kick it off, we're going to do 3 audience response questions quick. So please use the Blackberries. Mary, you can participate, too.
#1, what do you view as Mettler's organic growth profile over the next 3 years? I was going to joke. I think we've got 100% mid-single digits, before it was 89%. #2, how confident you are in the outlook for growth in China? 44%, confident. The rest, uncertain or not confident. And then, finally, how would you like to see Shawn deploy capital in 2019? Continue theme focused on investing in the core and M&A.
So Shawn, would you like to make any introductory comments?
Yes.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
